We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Alzheimer's Disease Gene Expression Varies by Brain Cell Type

By LabMedica International staff writers
Posted on 09 Dec 2019
Genetic variants in apolipoprotein E (APOE) and other genes have been implicated in late-onset Alzheimer's disease through genome-wide association studies and other analyses.

There is currently little information available about how individual cell types contribute to Alzheimer’s disease and about the relative contributions that different cell subpopulations make to Alzheimer's disease risk and development, despite evidence pointing to a potential role for genes and pathways involved in endocytosis, microglial function, and neuronal connectivity.

Scientists at Monash University (Clayton, Australia) applied single-nucleus RNA sequencing to entorhinal cortex samples from control and Alzheimer’s disease brains, yielding a total of 13,214 high-quality nuclei. More...
The team used a DroNc-Seq protocol with the 10x Genomics platform (Pleasanton, CA, USA) to generate high-quality nuclear RNA sequences for 13,214 cells from entorhinal cortex samples from six individuals with Alzheimer's disease and six unaffected controls matched for age and sex.

The team identified cell clusters that roughly coincided with microglia, astrocyte, neuron, oligodendrocyte progenitor cell, oligodendrocyte, and endothelial cell types by combining the single-cell transcriptomes in combination with spatial information produced using an approach known as ‘uniform manifold approximation and projection.’ The investigators reported that the Alzheimer's disease-related gene APOE was found at enhanced levels in a certain subpopulation of microglia cells, for example, but was dialed down in nuclei from other brain cell subpopulations, including the oligodendrocyte progenitor and astrocyte cell populations.

The scientists reported that the Alzheimer’s disease risk gene APOE is specifically repressed in Alzheimer’s disease oligodendrocyte progenitor cells and astrocyte subpopulations and upregulated in an Alzheimer’s disease-specific microglial subpopulation. Integrating transcription factor regulatory modules with Alzheimer’s disease risk loci revealed drivers of cell-type-specific state transitions towards Alzheimer’s disease. For example, transcription factor EB, a master regulator of lysosomal function, regulates multiple disease genes in a specific Alzheimer’s disease astrocyte subpopulation.

The authors concluded that in light of the complex genetic contributions to late-onset Alzheimer's disease, it is important to understand late-onset Alzheimer's disease, genome wide association studies (GWAS) gene involvement in cell-type-specific transcription factor networks that drive the transitions of cells from health to Alzheimer's disease states. The study was published on November 25, 2019 in the journal Nature Neuroscience.

Related Links:
Monash University
10x Genomics



Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Repetitive Pipette
VWR® Stepper Pro
New
Auto Chemiluminescence Immunoassay Analyzer
MT120S
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.